BAV Stock Chart & Stats
€0.14
>-€0.01(-2.50%)
At close: 4:00 PM EDT
€0.14
>-€0.01(-2.50%)
Day’s Range― - ―
52-Week Range€0.12 - €0.22
Previous CloseN/A
Volume0.00
Average Volume (3M)11.00
Market Cap
€45.96M
Enterprise Value€59.64M
Total Cash (Recent Filing)€22.50M
Total Debt (Recent Filing)€10.53M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Mar 17, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding436,874,180
10 Day Avg. Volume0
30 Day Avg. Volume11
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.44
Price to Sales (P/S)0.75
P/FCF Ratio-10.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€113.35M
Bulls Say, Bears Say
Bulls Say
Returning Revenue GrowthThe return to growth, followed by acceleration in 2025, indicates improving demand across the business after a period of stagnation. If maintained, stronger revenue momentum can broaden the operating base, support better absorption of fixed costs, and provide a foundation for restoring profitability.
Conservative LeverageLow leverage reduces the immediate burden of interest and refinancing obligations, giving BATM greater financial flexibility than a highly indebted business. This conservative capital structure can help preserve strategic options and provide some capacity to manage operating volatility while performance improves.
Diversified Technology ModelOperating across networking, telecom, and cybersecurity gives BATM multiple technology markets and customer groups rather than reliance on one product category. Its mix of direct sales and channel partners, alongside support and software-related revenues, can broaden distribution and deepen customer relationships.
Bears Say
Persistent Net LossesLarge recent net losses and weak operating profit show that revenue growth has not yet translated into dependable earnings. Even with the loss narrowing in 2025, continued margin weakness limits internal funding, reduces earnings visibility, and leaves the business exposed to further operating underperformance.
Negative Cash GenerationSustained negative operating and free cash flow means the business is currently consuming rather than producing cash from operations. If this persists, liquidity may come under pressure, investment capacity can be constrained, and BATM may have fewer resources available to support growth or absorb setbacks.
Eroding Equity BaseThe substantial decline in shareholders’ equity reflects the cumulative effect of multi-year losses and weak returns on capital. A smaller equity base reduces financial resilience, leaves less room to absorb additional losses, and makes a durable recovery in profitability more important for preserving balance-sheet strength.
BATM Advanced Communications News
BAV FAQ
What was BATM Advanced Communications’s price range in the past 12 months?
BATM Advanced Communications lowest stock price was €0.12 and its highest was €0.22 in the past 12 months.
What is BATM Advanced Communications’s market cap?
BATM Advanced Communications’s market cap is €45.96M.
When is BATM Advanced Communications’s upcoming earnings report date?
BATM Advanced Communications’s upcoming earnings report date is Mar 17, 2027 which is in 140 days.
How were BATM Advanced Communications’s earnings last quarter?
BATM Advanced Communications released its earnings results on Aug 24, 2026. The company reported -€0.005 earnings per share for the quarter.
Is BATM Advanced Communications overvalued?
According to Wall Street analysts BATM Advanced Communications’s price is currently Overvalued.
Does BATM Advanced Communications pay dividends?
BATM Advanced Communications does not currently pay dividends.
What is BATM Advanced Communications’s EPS estimate?
BATM Advanced Communications’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BATM Advanced Communications have?
BATM Advanced Communications has 436,874,180 shares outstanding.
What happened to BATM Advanced Communications’s price movement after its last earnings report?
BATM Advanced Communications reported an EPS of -€0.005 in its last earnings report. Following the earnings report the stock price went up 2.222%.
Which hedge fund is a major shareholder of BATM Advanced Communications?
Currently, no hedge funds are holding shares in DE:BAV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BATM Advanced Communications Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.48%
12-Months-Change
Fundamentals
Return on Equity
-25.90%
Trailing 12-Months
Asset Growth
―
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
BATM Advanced Communications
BATM Advanced Communications Ltd., together with its various group companies, delivers cutting-edge real-time technologies for both sophisticated networking solutions and advanced biomedical systems. The company operates across Israel, the United States, and Europe. It is structured into two primary business units: Networking and Cyber, and Bio-Medical. The Networking and Cyber division oversees the research, development, manufacturing, and marketing of data communication products. Its key offerings include network function virtualization, carrier Ethernet and MPLS access technologies, and systems for cyber network monitoring. This segment also provides a range of software services, such as training, technical assistance, and laboratory maintenance, in addition to undertaking construction contracts. Conversely, the Bio-Medical division concentrates on the innovation, production, commercialization, and distribution of medical products, with a particular emphasis on laboratory diagnostics and sterilization equipment. Its portfolio features molecular biology diagnostic tools and specialized systems for managing pathogenic and medical waste in critical environments like laboratories, hospitals, pharmaceutical manufacturing plants, and agricultural settings. This division also acts as a distributor for a broad array of diagnostic apparatus and medical consumables from various manufacturers. Notably, BATM has entered into a significant partnership with Novamed Ltd to collaboratively develop and market a home-use testing kit for COVID-19. Established in 1992, the company's corporate headquarters are situated in Hod Hasharon, Israel.
Technical Analysis
EKF Diagnostics Holdings
―
Omega Diagnostics
―
Renalytix
―
Diaceutics
―
Abingdon Health PLC
―







